release. Myofilament sensitivity to Ca 2? was not changed by K201. Confocal microscopy revealed diastolic events composed of multiple Ca 2? waves (2-3) originating at various points along the cardiomyocyte length during each diastolic period. 1.0 lmol/L K201 significantly reduced the (a) frequency of diastolic events and (b) initiation points/ diastolic interval in the remaining diastolic events to 61% and 71% of control levels respectively. 1.0 lmol/L K201 can reduce the probability of spontaneous diastolic Ca 2? release and their associated contractions which may limit the propensity for the contractile dysfunction observed in vivo.
Abstract K201 has previously been shown to reduce diastolic contractions in vivo during b-adrenergic stimulation and elevated extracellular calcium concentration ([Ca 2? ] o ). The present study characterised the effect of K201 on electrically stimulated and spontaneous diastolic sarcoplasmic reticulum (SR)-mediated Ca 2? release and contractile events in isolated rat cardiomyocytes during b-adrenergic stimulation and elevated [Ca 2? ] o . Parallel experiments using confocal microscopy examined spontaneous diastolic Ca 2? release events at an enhanced spatiotemporal resolution. 1.0 lmol/L K201 in the presence of 150 nmol/L isoproterenol (ISO) and 4.75 mmol/L [Ca 2? ] o significantly decreased the amplitude of diastolic contractions to *16% of control levels. The stimulated free Ca 2? transient amplitude was significantly reduced, but stimulated cell shortening was not significantly altered. When intracellular buffering was taken into account, K201 led to an increase in action potential-induced SR Ca 2? release. Myofilament sensitivity to Ca 2? was not changed by K201. Confocal microscopy revealed diastolic events composed of multiple Ca 2? waves (2-3) originating at various points along the cardiomyocyte length during each diastolic period. 1.0 lmol/L K201 significantly reduced the (a) frequency of diastolic events and (b) initiation points/ diastolic interval in the remaining diastolic events to 61% and 71% of control levels respectively. 1.0 lmol/L K201 can reduce the probability of spontaneous diastolic Ca 2? release and their associated contractions which may limit the propensity for the contractile dysfunction observed in vivo.
Keywords Calcium Á K201 Á JTV-519 Á Sarcoplasmic reticulum Á Calcium waves release via the ryanodine receptor, RyR2) is altered in almost all models of heart failure and may lead to abnormal myocardial relaxation and filling during diastole [5, 6, 15, 22] . While many studies have correlated the consequences of altered SERCA-mediated Ca 2? uptake and diastolic dysfunction (DD) [1, 20] , few have investigated the consequences of abnormal diastolic SR Ca 2? release on whole heart contractile function. To address this issue, a recent study by the authors demonstrated that while in vivo administration of a b-adrenergic agonist or an elevated extracellular calcium concentration ([Ca 2? ] o ) separately did not produce any significant alteration of diastolic function in rat hearts, co-administration of a b-adrenergic agonist and an elevated [Ca 2? ] o led to an acute onset of DD [13] . A b-adrenergic agonist was used in this in vivo model to stimulate a PKA-mediated increase in SR Ca 2? load. When combined with an elevated [Ca 2? ] o , DD manifest as diastolic contractions, a raised end-diastolic pressure (EDP) but no alteration of ejection fraction [13] .
K201 (JTV-519), a 1,4 benzothiazepine derivative structurally distinct from diltiazem, was originally discovered when screening compounds to prevent sudden cardiac cell death in a rat Langendorff model of myofibrillar over-contraction [12] . The drug has been suggested to improve contractile function in heart failure via a sole inhibitory effect on diastolic RyR2-mediated SR Ca 2? release [27, 29] . However, it is clear from the literature that K201 exhibits effects on additional cellular targets in a species-specific manner [3] . In guinea pig cardiomyocytes, K201 inhibits sodium (I Na ) [16] and potassium currents (I K1 , I Kr ) [16, 17] and prolongs action potential duration [17] , yet the effect on these targets has not been determined in alternative species. Investigations of the effect on L-type calcium current (I Ca ) have yielded contrasting results with inhibition in the rat and guinea pig [11, 14] , whilst no effect in the rabbit [18] . Inhibition of SERCA activity by K201 in rabbit cardiomyocytes has been demonstrated previously, but the effect in rat is unknown [18] . In the above rat model of DD, K201 limits diastolic contractures and reduces EDP [14] in vivo; however, the cellular mechanisms underlying these phenomena are unknown. It is possible that the observed benefit of K201 in vivo could originate from the drugs ability to (a) inhibit abnormal diastolic Ca 2? release events leading to improved contractile performance or (b) alteration of myofilament Ca 2? sensitivity. To test these hypotheses and given K201's species specificity, this study was designed to characterise the effect of K201 on: (a) the stimulated Ca 
Materials and methods

Adult rat ventricular cardiomyocyte isolation
Adult male Wistar rats (200-300 g, 8-9 weeks in age, n = 23) were euthanased using a schedule one procedure in accordance with the UK Animals (Scientific Procedures) Act 1986. Hearts were removed and perfused retrogradely at 5 mL min -1 (37°C) with a modified isolation KrebsHenseleit (KH) solution for 4 min. The composition of the isolation KH was (in mmol/L): NaCl (120), KCl (5.4), HEPES (20) , Na H 2 PO 4 (0.52), MgCl 2 6H 2 O (3.5), taurine (20) , creatine (10), glucose (11.1), pH 7.4 with NaOH. This was followed by perfusion with KH containing 1 mg mL
collagenase (type I, Worthington Biochemical, Lakewood, NJ, USA), and 0.1 mg ml -1 protease (type XIV, SigmaAldrich, UK). After *6.0 min, enzyme was removed and the heart perfused with nominally Ca 2? -free isolation KH solution containing 1% BSA (Sigma-Aldrich, UK) for a further 6.0 min. The left ventricular free wall was then cut into strips and mixed to yield a single cell suspension. Cells were maintained in either Ca 2? -free isolation KH solution or 1.0 mmol/L Ca 2? (via stepwise increments) until use.
Field stimulation of intact cardiomyocytes with simultaneous whole cell epi-fluorescence and shortening measurements Intact cardiomyocytes in modified isolation KH solution (above) were loaded with a Ca 2? sensitive fluorophore (5.0 lmol/L Fura-4F AM, Invitrogen, UK) by incubation for *10 min. The incubation medium was removed and the cells re-suspended in a second modified KH solution with the following composition (in mmol/L): NaCl (140), KCl (4.0), MgCl 2 (1.0), HEPES (5.0), glucose (11.1), pH 7.4 with NaOH with 1.25 mmol/L [Ca 2? ] added. Cells were incubated for a further 30 min to ensure complete deesterification. Cardiomyocytes were allowed to settle on a coverslip, placed on a bath (Cell Microcontrols, Norfolk, VA, USA) and super-fused with the same modified KH solution at 37°C. Cells were field stimulated with 2 ms duration voltage pulses delivered through parallel platinum wires (stimulation voltage set to 1.5 times the threshold). K201 (a gift from Aetas Pharma Co. Ltd., Japan) was prepared at a stock concentration of 1.0 mmol/L in 10% DMSO; the final concentration of K201 in the perfusate was 1.0 lmol/L. A parallel set of vehicle (DMSO) time control experiments were performed; all data obtained in K201 were normalised to these timed controls. The Fura-4F fluorescence (340 and 380 nm excitation; R 340/380nm ) was measured using a spinning wheel spectrophotometer (Cairn Research Ltd., UK; sampling rate of 500 Hz) whilst cellular shortening was measured using a video edge detection system (IonOptix, Milton, MA, USA; sampling rate of 200 Hz). Data were analysed offline. Fura-4F fluorescence ratio was converted to intracellular [ 
Results
Measurement of spontaneous diastolic events in isolated ventricular cardiomyocytes
To gain an insight into the cellular mechanisms which contribute to the beneficial effect of K201 in a previously published pharmacologically induced in vivo rat model of diastolic dysfunction [14] events in all cells tested (100%) and, in *50% cells, these were completely abolished ( Fig. 1b(iii) ). The mean response to K201 was to significantly reduce both the amplitudes of diastolic Ca channel amplitude in response to 1.0 lmol/L K201 (95.6 ± 4.4% of timed control level-see Online resource III). The effect of K201 on the overall electrical activity of ventricular cells was assessed from ECG measurements on isolated Langendorff perfused whole hearts (see Online resource IV). These revealed no significant differences in QT interval at a fixed stimulus rate suggesting no major change in action potential duration in rat hearts exposed to 1.0 lmol/L K201.
Effects of K201 on myofilament Ca 2? sensitivity An assessment of the ability of K201 to alter myofilament Ca 2? sensitivity was made as this was a previously proposed mechanism to explain the in vivo improvement of function in the rat [14] . alone (in Fig. 2a) extrusion, these rates were not altered following K201 (1.35 ± 0.15 vs. 1.21 ± 0.15 lmol/L s -1 ; ISO vs. K201; n = 8, P [ 0.05; data not shown).
Given the dramatic reduction in the amplitude of diastolic Ca 2? release events by K201, the [Ca 2? ] i immediately preceding the stimulus (pre-stim) was lower after K201 (see Fig. 1c(ii) ). The consequences of this alteration in diastolic Ca 2? level at the point of action potentialinduced Ca 2? release must be considered when assessing the effect of K201 on the Ca 2? transient amplitude. To allow for varying degrees of intracellular buffering of SR release under these two conditions, mean traces were converted to total cellular [Ca 2? ] using previously reported intracellular buffer concentrations and affinities (Fig. 3b(i, ii) , [8] ] i showed no significant difference between SR content in ISO and K201 (Fig. 3c(iii) ).
Characterisation of the stimulated Ca 2? transients shown in Fig. 1 revealed that whilst 1.0 lmol/L K201 did not alter the maximum rate of rise of the stimulated Ca release events at an enhanced spatiotemporal resolution, a set of experiments was performed using confocal imaging of rat cardiomyocytes perfused with the same [Ca 2? ] o and additions as in Fig. 1 (Fig. 4a) Fig. 4b(ii) vs. b(i) top panels) and corresponding fluorescence intensity profiles (Fig. 4b(ii) vs. b(i) bottom panels). Diastolic Ca 2? events were initiated at discrete points along the scan line (Fig. 4b(ii) top panel) and then propagated along the cell length identifying these diastolic events as being the result of multiple Ca 2? waves. Initiation points of the Ca 2? waves were identified on the basis of evidence from the line scan image of propagation away from a separate site. The number of initiation points which 2? waves was markedly increased when ISO was added to the perfusing solution and typically resulted in multiple waves in the diastolic interval (Fig. 4b(ii) top  panel) . Application of 1.0 lmol/L K201 caused a significant reduction in the frequency of diastolic events (12.45 ± 1.36 vs. 7.55 ± 1.53 diastolic events/15 s period; ISO vs. K201: n = 11, P \ 0.05-data not shown) and, as illustrated in Fig. 4b(iii) and c(i) , a significant reduction in the initiation points/diastolic interval in the remaining diastolic Ca 2? release events [1.43 ± 0.09 vs. 1.02 ± 0.02; ISO vs. K201: n = 11, P \ 0.05; Fig. 4c(i) ]. This was accompanied by no significant change in stimulated transient peak fluorescence but a significant reduction in the fluorescence measured at 950 ms post stimulation compared to control [2.33 ± 0.20 vs. 1.48 ± 0.15 F/F 0 ; ISO vs. K201: n = 11, P \ 0.05; Fig. 4c(ii) (Fig. 5a ). Confocal images obtained from these cells showed a synchronous rise of [Ca 2? ] i at each stimulation point and multiple waves originating at various initiation points during the diastolic interval (Fig. 5b(i) ). Application of 1.0 lmol/L K201 without ISO (referred to ] o and ISO were examined as in Fig. 6a (i-iii) with respective fluorescence intensity profiles (Fig. 6b top-bottom) . Number of initiation points (highlighted by red circles- Fig. 6a ) per diastolic event was plotted against the amplitude of that event (Fig. 6c) . The mean data showed a positive correlation between the two parameters with significant differences between 1, 2 and 3 initiation points (1.06 ± 0.1, 1.87 ± 0.1, 2.58 ± 0.26 F/F 0; P \ 0.05; Fig. 6c ), respectively.
Discussion
We have provided for the first time a detailed characterisation of the effects of K201 on the stimulated Ca ] o in rat cardiomyocytes. Our main findings are: (a) K201 has no effect on stimulated cell shortening but significantly reduces spontaneous diastolic contractile events induced by elevated Ca 2? loading, (b) K201 produces a small but significant reduction in stimulated free Ca 2? transient amplitude and significantly reduces spontaneous Ca 2? release events with no alteration in SR Ca 2? content, (c) when intracellular buffering is taken into account, K201 produces a significant increase in total Ca 2? transient amplitude, (d) K201 had no effect on myofilament Ca 2? sensitivity thereby discounting this previously proposed mechanism to explain the in vivo improvement of function in the rat [14] , (e) 1.0 lmol/L K201 does not inhibit SERCA in rat cardiomyocytes (which is in contrast to the effect in rabbit [18] ) and (f) spontaneous diastolic Ca 2? events occurred in the form of multiple propagating Ca 2? waves (each with an initiating point) and that K201 acts to reduce both the event frequency and number of initiation points per diastolic event.
Comparison between the effect of K201 on diastolic contractions in vivo and in isolated cardiomyocytes A previous study has demonstrated that in vivo application of a b-adrenergic agonist and an elevated [Ca 2? ] o led to the production of diastolic contractions resulting in a raised intra-ventricular pressure measured at the R wave [14] . This pharmacological intervention resulted in a model of severe acute diastolic dysfunction without a significant change in systolic peak pressure. Application of 1.0 lmol/ L K201 in vivo reduced the occurrence of the diastolic contractures and significantly reduced the mean intra-ventricular pressure measured at the R wave with no significant alteration of the peak pressure. With the caveat that detailed comparison of contractile function between isolated cardiomyocyte and whole heart experiments is Fig. 4  (1, 2 and 3 initiation points, n = 42, 30 and 6 diastolic Ca 2? events, respectively, *P \ 0.05) problematic, the aforementioned effect of K201 on the mechanical function of the whole rat heart demonstrates some similarities to shortening measurements in isolated rat cardiomyocytes performed in this study (Fig. 1) . In the present study, b-adrenergic stimulation of ventricular cardiomyocytes perfused with an elevated [Ca 2? ] o also led to the production of spontaneous diastolic cellular contractions. The amplitude of the spontaneous diastolic contractures was significantly reduced by K201 (to *16% of control) with no alteration of the stimulated shortening amplitude. One difference between the in vivo rat study and the isolated cardiomyocyte experiments is the response of the cells in the current study with elevated [Ca 2? ] o to ISO, which resulted in a positive ionotropy (Fig. 1d(iii) Fig. 3a(ii) (Fig. 2) . This relationship was unaltered in the presence of a range of K201 concentrations or an alternative benzothiazepine derivative (diltiazem) thereby demonstrating that K201 does not alter the sensitivity of the myofilaments under these conditions. Further verification of this was obtained via direct myofilament measurements performed in permeabilised rat ventricular cardiomyocytes at a free [Ca ] i ; this may reflect the lack of effect of K201 on sarcolemmal extrusion as previously reported [18] . [4, 25] . The current study observed significant inhibition of diastolic Ca 2? spark activity by 1.0 lmol/L K201 supporting the concept that K201 reduces the activity of RyR2 but no significant difference in SR content was observed. However, due to the cell-to-cell variability in the caffeine response it is acknowledged that the measurements in the current study may have been unable to discriminate a *10-12% change in SR Ca 2? content. Despite this limitation, it should be recognised that K201 is not the only drug which demonstrates inhibition of RyR2 without a concomitant increase in SR Ca 2? content. Flecainide has been reported to reduce Ca 2? wave amplitude in permeabilised rat cardiomyocytes without alteration in the SR Ca 2? content or SERCA activity. This is thought to have been achieved by inhibition of RyR2 via an open state block; under these circumstances comparable leak is achieved via significantly higher spark rates despite a significantly reduced ''spark mass'' [7] .
The effect of K201 on the Ca 2? transient amplitude K201 has been shown to prevent diastolic dysfunction and improve systolic function during Ca 2? overload conditions in terminally failing human myocardial preparations [24] . In contrast to the current study, no direct measurements of the Ca 2? transient or [Ca 2? ] i were performed. In another previous study by the authors, on this occasion in rabbit cardiomyocytes, the amplitude of depolarisation-induced Ca 2? transients was reduced by 1.0 lmol/L K201 but this did not reach significance [18] . Cellular shortening measurements were not reported in this previous work. The current study permits further insight into the effects of K201 using a fluorophore (Fura 4F AM) with a lower affinity which is able to determine the systolic [Ca 2? ] transient with more accuracy [28] . These novel data suggest that the action potential-induced free Ca 2? transients demonstrate a small but significant reduction in amplitude in response to 1.0 lmol/L K201. These changes occurred in the absence of major changes in ventricular electrophysiology (ECG recordings; Online resource IV) or the activity of common Ca 2? handling proteins, e.g. SERCA or NCX (see Online Resource V). In particular, 1.0 lmol/L K201 caused only a small decrease (*5%) in I Ca amplitude in the presence of an elevated [Ca 2? ] o . This contrasts with a previous study which showed a reduction of I Ca peak by 22% in rat cardiomyocytes [10] , but is similar to the *3% reduction observed in rabbit cardiomyocytes [18] . This slight reduction in I Ca (*5%) would not be expected to cause a significant ([5%) change in Ca 2? transient amplitude [9] . Superficially, it would appear difficult to reconcile the absence of the effects of K201 on SR Ca 2? content and I Ca with the reduction in the peak of the stimulated free Ca 2? transient. Particularly, since K201 was very effective in inhibiting spontaneous diastolic Ca 2? release which should result in more Ca 2? being available for release on the subsequent stimulus. The reconciliation of these data comes when allowance is made for the intracellular buffering which, as shown by previous studies [8] wave and the inward current generated [19] . While there is an established link between Ca 2? waves and electrical abnormalities, the link between Ca 2? waves and mechanical dysfunction is less clear. To ascertain the spatiotemporal properties of the spontaneous diastolic Ca 2? release events, confocal microscopy of ventricular cardiomyocytes was employed using a similar protocol to that in Fig. 1 . The experiments revealed that the diastolic events were predominantly in the form of propagating Ca 2? waves (Figs. 4, 5 ), which were significantly reduced in frequency and amplitude by 1.0 lmol/L K201. Characterisation of these events revealed multiple initiating points, the number of which was reduced upon application of 1.0 lmol/L K201. Thus, whilst K201 acts to significantly reduce the probability of spontaneous diastolic events (by *50%) it also acts to modulate the characteristics of the remaining events. The significance of the transition in the latter is illustrated in Fig. 6 . Diastolic Ca 2? events with multiple initiation points ( Fig. 6a(iii vs. ii) ) tend towards being more synchronous in activation (similar to the stimulated Ca 2? transient ( Fig. 6a  (i) ). Analysis of the whole cell fluorescence (Fig. 6b) reveals that the larger number of initiation points results in a larger amplitude of spontaneously released Ca 2? from the SR (Fig. 6b (bottom) ) and hence may increase the propensity to generate a transient inward current. This is summarised in the mean data presented in Fig. 6c , which demonstrate that for every extra initiation point per diastolic Ca 2? event during a short diastolic interval, the amplitude of the global Ca 2? release increases by *1.8 times. Conversely, a reduction in the number of these initiation points (Fig. 6b  (middle) ) would be expected to lead to a reduction in Ca 2? available for extrusion at any one time by NCX. An insight into the net effect of this response to K201 in a multi-cellular preparation can be seen in the averaged traces of [Ca 2? ] i and contraction (Online Resource Ia).
Synchronicity of initiation points in the ISO data set (Fig. 4) was measured using the time between the first and last initiation point in each diastolic interval. This value was then correlated with the Ca 2? spark frequency in that cell. In cells with low spark frequency (6.0 ± 1.1/100 lm/s), the initiation points were on average 120.4 ± 13.9 ms between the first and last wave in a diastolic interval. In cells with a much higher spark frequency (35.4 ± 1.1/100 lm/s), the initiation points were on average 69.4 ± 7.3 ms between the first and last wave in a diastolic interval. This proved to be a significant correlation (P \ 0.05). In these two subgroups, Ca 2? spark amplitude was, however, not significantly different. Therefore, while the action of K201 to reduce Ca 2? spark frequency (albeit not significantly, see online resource VI) may lead to a reduction in the synchronicity of Ca 2? initiation points, the effect is not enough to explain the reduction in number of Ca 2? initiation points.
Is the effect of K201 on Ca 2? waves related to b-adrenergic antagonism?
It is possible that the effect of K201 to reduce diastolic Ca 2? release event amplitude and number of initiation points in this study is due to an ability of K201 to antagonise the effect of b-adrenergic stimulation. While the results in Fig. 5 cannot discount this hypothesis, it seems unlikely given that in the sub-set of cells where Ca 2? waves were produced in the absence of b-adrenergic stimulation, the effect of K201 to limit these Ca 2? waves was identical to that in the presence of b-adrenergic stimulation (Fig. 4 ).
Summary and conclusion
The anti-arrhythmic effect of K201 has been attributed to reducing the open probability of RyR2 thus preventing excessive diastolic SR mediated Ca 2? leak [26] . This study provides several new mechanistic insights which advance our knowledge of K201. For the first time, we have examined the effect of K201 on intracellular Ca 2? and contractile function of isolated rat cardiomyocytes and have shown the drug significantly inhibits diastolic Ca 2? release and their associated contractile events leading to an increased action potential-induced SR Ca 2? release. These effects occur in the absence of altered myofilament Ca 2? sensitivity. Our data also provide greater insight into the effect of K201 on the spatiotemporal properties of Ca 2? handling introducing the concept that a reduction in Ca 2? wave initiation points has the potential to be anti-arrhythmic due to the limitation of the amplitude of the Ca 2? wave and subsequent increase in transient inward current. This may therefore be a route through which both the deleterious arrhythmogenic and mechanical effects of Ca 2? waves can be limited.
